Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Miller Richard A Md
Relationship:   Director
City:   Sunnyvale
State:   CA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   893,366    

Indirect Shares

   1,214,771      
Direct Value   $1,259,495    

Indirect Value

   $2,566,302      
Total Shares   2,108,137      
Total Value   $3,825,798      


Pharmacyclics Inc $0 Corvus Pharmaceuticals, Inc. $1,247,689 Bolt Biotherapeutics, Inc. $11,806 Pharmacyclics Inc $0 Corvus Pharmaceuticals, Inc. $1,247,689 Bolt Biotherapeutics, Inc. $11,806
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    15   
    0    

     Stock price went up :
    6   
    0    
     Stock price went down :
    9   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   41.5%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Pharmacyclics Inc PCYC Pres, CEO & Director, ... 2007-08-22 300,130 2007-08-22 26,668    Premium*  
            Corvus Pharmaceuticals, Inc. CRVS 2024-05-10 577,634 2024-05-10 1,188,103    Premium*  
            Bolt Biotherapeutics, Inc. BOLT Director 2021-02-04 15,602 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
PCYC Pharmacyclics Inc Pres, CEO & Director   •       •      –    2005-08-01 4 D $9.25 $1,100,010 D/D (118,920) 143,463 -
PCYC Pharmacyclics Inc Pres, CEO & Director   •       •      –    2005-08-01 4 OE $7.50 $1,100,003 D/D 146,667 290,130 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2024-05-06 4 B $1.73 $1,000,000 D/D 577,634 577,634 0.01 %
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2018-03-12 4 B $8.50 $850,000 I/I 100,000 1,112,293 2.66 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2021-02-17 4 B $3.50 $350,000 I/I 100,000 1,278,515 2.66 %
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2016-05-12 4 B $10.00 $300,000 I/I 30,000 1,076,993 2.66 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2017-06-12 4 B $9.82 $110,185 I/I 11,216 997,293 2.66 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2017-11-20 4 B $10.79 $107,850 I/I 10,000 1,012,293 2.66 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2021-05-04 4 B $2.80 $99,999 D/D 35,714 35,714 2.81 %
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2017-06-09 4 B $9.89 $87,174 I/I 8,784 986,077 2.66 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2018-12-27 4 B $3.29 $65,884 I/I 20,000 1,128,795 2.66 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2017-06-13 4 B $9.75 $49,725 I/I 5,000 1,002,293 2.66 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2019-11-13 4 B $3.00 $44,240 I/I 14,736 1,178,515 2.66 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2018-12-20 4 B $4.39 $43,950 I/I 10,000 1,108,795 2.66 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2019-06-14 4 B $3.40 $39,666 I/I 11,657 1,156,007 2.66 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2022-12-13 4 B $0.74 $37,015 I/I 50,000 1,480,119 2.66 %
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2022-03-15 4 B $1.47 $36,650 I/I 25,000 1,313,515 2.66 %
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2019-06-07 4 B $3.37 $31,019 I/I 9,212 1,138,007 2.66 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2018-12-06 4 B $5.99 $29,934 I/I 5,000 1,118,795 2.66 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2022-03-31 4 B $1.64 $24,534 I/I 15,000 1,333,515 2.58 %
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2019-06-11 4 B $3.67 $22,020 I/I 6,000 1,144,007 2.58 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2021-08-20 4 B $1.93 $19,254 I/I 10,000 1,288,515 2.58 %
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2022-09-28 4 B $0.76 $19,070 I/I 25,000 1,394,405 2.58 %
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2019-08-06 4 B $3.58 $17,875 I/I 5,000 1,161,007 2.58 -
CRVS Corvus Pharmaceuticals, I... President and CEO   •       •      –    2022-09-20 4 B $0.81 $16,253 I/I 20,000 1,369,405 2.58 %
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us